It is known that PTVs in the last exon of PPM1D specifically that carry ‘‘gain-of-function’’ effect are enriched in cases of breast and ovarian cancer.1 We observed the same enrichment in our data set—of 18 mosaic PTVs in PPM1D, 17 were in the last exon of the gene. The gene discussed is PPM1D; the disease is ovarian cancer.